306 related articles for article (PubMed ID: 33599895)
1. Regulation of aromatase in cancer.
Molehin D; Rasha F; Rahman RL; Pruitt K
Mol Cell Biochem; 2021 Jun; 476(6):2449-2464. PubMed ID: 33599895
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aromatase expression: Potential therapeutic insight into breast cancer treatment.
Molehin D; Filleur S; Pruitt K
Mol Cell Endocrinol; 2021 Jul; 531():111321. PubMed ID: 33992735
[TBL] [Abstract][Full Text] [Related]
3. Overcoming aromatase inhibitor resistance in breast cancer: possible mechanisms and clinical applications.
Hanamura T; Hayashi SI
Breast Cancer; 2018 Jul; 25(4):379-391. PubMed ID: 28389808
[TBL] [Abstract][Full Text] [Related]
4. Aromatase inhibitors in ovarian cancer: is there a role?
Li YF; Hu W; Fu SQ; Li JD; Liu JH; Kavanagh JJ
Int J Gynecol Cancer; 2008; 18(4):600-14. PubMed ID: 17894799
[TBL] [Abstract][Full Text] [Related]
5. Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women.
Gibson LJ; Dawson C; Lawrence DH; Bliss JM
Cochrane Database Syst Rev; 2007 Jan; (1):CD003370. PubMed ID: 17253488
[TBL] [Abstract][Full Text] [Related]
6. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
[TBL] [Abstract][Full Text] [Related]
8. Stroma-mediated expression of estrogen and its role in cancer.
Sachdeva M; Mo YY
Front Biosci (Landmark Ed); 2010 Jan; 15(1):237-48. PubMed ID: 20036818
[TBL] [Abstract][Full Text] [Related]
9. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
10. Aromatase Inhibitors for the Treatment of Breast Cancer: A Journey from the Scratch.
Ratre P; Mishra K; Dubey A; Vyas A; Jain A; Thareja S
Anticancer Agents Med Chem; 2020; 20(17):1994-2004. PubMed ID: 32593281
[TBL] [Abstract][Full Text] [Related]
11. Reconsidering Aromatase for Breast Cancer Treatment: New Roles for an Old Target.
Caciolla J; Bisi A; Belluti F; Rampa A; Gobbi S
Molecules; 2020 Nov; 25(22):. PubMed ID: 33207783
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity.
Kazi A; Goloubeva O; Schech A; Yu S; Sabnis GJ
J Steroid Biochem Mol Biol; 2020 Sep; 202():105697. PubMed ID: 32461092
[TBL] [Abstract][Full Text] [Related]
13. Effects of new C6-substituted steroidal aromatase inhibitors in hormone-sensitive breast cancer cells: Cell death mechanisms and modulation of estrogen and androgen receptors.
Augusto TV; Amaral C; Varela CL; Bernardo F; da Silva ET; Roleira FFM; Costa S; Teixeira N; Correia-da-Silva G
J Steroid Biochem Mol Biol; 2019 Dec; 195():105486. PubMed ID: 31557516
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
15. Gene expression alterations associated with outcome in aromatase inhibitor-treated ER+ early-stage breast cancer patients.
Thomsen KG; Lyng MB; Elias D; Vever H; Knoop AS; Lykkesfeldt AE; Lænkholm AV; Ditzel HJ
Breast Cancer Res Treat; 2015 Dec; 154(3):483-94. PubMed ID: 26585578
[TBL] [Abstract][Full Text] [Related]
16. What do we know about the mechanisms of aromatase inhibitor resistance?
Chen S; Masri S; Wang X; Phung S; Yuan YC; Wu X
J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):232-40. PubMed ID: 17055257
[TBL] [Abstract][Full Text] [Related]
17. Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis.
Amaral C; Varela C; Borges M; Tavares da Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
Apoptosis; 2013 Nov; 18(11):1426-1436. PubMed ID: 23842740
[TBL] [Abstract][Full Text] [Related]
18. Effects of steroidal aromatase inhibitors on sensitive and resistant breast cancer cells: aromatase inhibition and autophagy.
Amaral C; Varela C; Azevedo M; da Silva ET; Roleira FM; Chen S; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2013 May; 135():51-9. PubMed ID: 23318878
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant trials of aromatase inhibitors: determining the future landscape of adjuvant endocrine therapy.
Ragaz J
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):133-41. PubMed ID: 11850217
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.
Manna PR; Molehin D; Ahmed AU
Prog Mol Biol Transl Sci; 2016; 144():487-537. PubMed ID: 27865465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]